A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

PHASE2CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

August 25, 2022

Study Completion Date

November 22, 2022

Conditions
ObesityOverweight and Obesity
Interventions
DRUG

LY3502970

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (35)

1032

Szent Margit Rendelőintézet Nonprofit Kft, Budapest

1033

Clinexpert Kft., Budapest

1213

TRANTOR'99 Bt. Anyagcsere Centrum, Budapest

3200

Bugát Pál Kórház, Gyöngyös

4032

Debreceni Egyetem Klinikai Kozpont, Debrecen

6300

Studium Egeszseghaz Kft, Kalocsa

8230

DRC Gyógyszervizsgáló Központ, Balatonfüred

8800

Kanizsai Dorottya Korhaz, Nagykanizsa

15243

Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh

17011

Capital Area Research, LLC, Camp Hill

23294

National Clinical Research, Inc, Richmond

54303

St. Vincent Hospital d/b/a Prevea Health, Green Bay

58104

Lillestol Research, Fargo

63303

StudyMetrix Research, City of Saint Peters

73069

Intend Research, LLC, Norman

75230

Dallas Diabetes Research Center, Dallas

76132

Diabetes and Thyroid Center of Fort Worth, Fort Worth

78681

Texas Diabetes & Endocrinology, P.A., Round Rock

83221

Elite Clinical Trials, Blackfoot

83404

Rocky Mountain Clinical Research, Idaho Falls

91325

Valley Clinical Trials, Inc., Northridge

92801

Anaheim Clinical Trials, LLC, Anaheim

94520

John Muir Physician Network Research Center, Concord

94583

Norcal Endocrinology & Internal Medicine, San Ramon

94904

NorCal Medical Research, Inc, Greenbrae

08611

Premier Research, Trenton

T2V 4J2

C-health Research, Calgary

L8L 5G8

Wharton Medical Clinic, Hamilton

N7T 4X3

Bluewater Clinical Research Group Inc., Sarnia

G0A 4B0

Centre Médical et Professionnel de l'Ouest de Portneuf, Saint-Marc-des-Carrieres

G2J 0C4

Alpha Recherche Clinique, Québec

G3K 2P8

ALPHA Recherche Clinique, Québec

H1171

Strazsahegy Medicina Bt., Budapest

00717

Puerto Rico Medical Research, Ponce

Research and Cardiovascular Corp., Ponce

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities | Biotech Hunter | Biotech Hunter